semaglutide updates Medication Safety Update: Rybelsus® (semaglutide tablets), The MHRA has issued a safety alert regarding the transition to a new formulation of Rybelsus®., During the transition period, both Pediatric Obesity Research Update |

Large-scale production in China and India has solidified this segments leadership position

Most research supports 1.21.6 g of protein per kg of body weight per day for anyone in active weight loss, and potentially higher on GLP-1 medications where muscle loss risk is elevated

Watch for these symptoms: Dry mouth Dark urine Dizziness Palpitations Marked weakness Seek medical advice if symptoms are persistent or severe

Approximately half of all US adults may be eligible for a GLP-1 prescription

Covariates Data on covariates were obtained using ICD-8 (19771993) and ICD-10 (19932018) codes ( Supplemental Table S2 ), ATC codes (19952018) ( Supplemental Table S3 ), or a combination of both ( Supplemental Table S4 )